Skip to main content
Tech.euFundingExplorerBeta

Foresite Capital

Investor profile

Foresite Capital has backed 2 European tech companies across 3 funding rounds between 2020 and 2023, joining rounds totalling €139M. Most active in Healthtech. Data as of 4 Nov 2026.

Deals
3
distinct rounds
Companies
2
backed
Active span
2020–2023
4 yrs
Total round €
€139M
sum of rounds joined

Deals by year

distinct rounds / year
Foresite Capital — deals by year — interactive chart.
Data table
Foresite Capital — deals by year
20201
20211
20231

Top sectors

by deals
Foresite Capital — top sectors — interactive chart.
Data table
Foresite Capital — top sectors
Healthtech3

Stages

by deals
Foresite Capital — stages — interactive chart.
Data table
Foresite Capital — stages
Series B3

Countries

by deals
Foresite Capital — countries — interactive chart.
Data table
Foresite Capital — countries
UK3

Co-investment network

shared rounds
Co-investment network — interactive chart.
Foresite Capital — 3 dealsForesite CapitalARCH Venture Partners — 1 shared deals · click to openARCH Venture PartnersCambridge Consultants — 1 shared deals · click to openCambridge ConsultantsCharles River Laboratories — 1 shared deals · click to openCharles River LaboratoriesCivilization Ventures — 1 shared deals · click to openCivilization VenturesDCVC — 1 shared deals · click to openDCVCMetaplanet — 1 shared deals · click to openMetaplanetMolten Ventures — 1 shared deals · click to openMolten VenturesMorningside Ventures — 1 shared deals · click to openMorningside VenturesProvidence Ventures — 1 shared deals · click to openProvidence VenturesPuhua Capital — 1 shared deals · click to openPuhua CapitalResilience — 1 shared deals · click to openResilienceTencent — 1 shared deals · click to openTencent

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
bit.bioUK1€89M
EvonetixUK2€50M

Biggest deals

top 10 by amount
CompanyStageAmountDate
bit.bioSeries B€89M2021-11
EvonetixSeries B€27M2020-02
EvonetixSeries B€22M2023-02
← Back to investors